Robert Alan Vigersky MD
Diabetes, Lipid Metabolism
Professor, Medicine, Uniformed Services Hebert SOM
Join to View Full Profile
8901 Rockville PikeBldg WalterBethesda, MD 20889
Phone+1 301-295-5165
Fax+1 301-295-5170
Dr. Vigersky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1972
Boston University School of MedicineClass of 1970
Certifications & Licensure
DC State Medical License 1978 - 2027
MD State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Continuous Glucose Monitoring in Patients With Type 2 Diabetes Start of enrollment: 2007 Sep 01
- Blood Sugar Response to Commercial Nutritional Supplements in Patients With Type 2 Diabetes Start of enrollment: 2006 May 01
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- Automated insulin delivery with the MiniMed™ 780G system reduces burden by improving sleep and glycaemic control overnight.Jennifer J F McVean, Fang Niu, Margaret Liu, Arcelia Arrieta, Naveen Sathiyanathan
Diabetes, Obesity & Metabolism. 2026-01-08 - MiniMed 780G Advanced Hybrid Closed-Loop System Use During Days Without User-Initiated Boluses.Fang Niu, Margaret Liu, Caroline Yovanovich, Robert A Vigersky, John J Shin
Diabetes Care. 2026-01-07 - Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States.Albert Chien, John J Shin, Margaret Liu, Arcelia Arrieta, Toni L Cordero
Diabetes Technology & Therapeutics. 2025-12-01
Press Mentions
Data Backs Medtronic MiniMed 780G for Type 2, Children as Company Seeks Expanded IndicationsJune 20th, 2025- FDA Rules Medtronic’s Insulin Pump Issues a Class I Recall Due to Safety RisksOctober 4th, 2024
- Increasing Access to Diabetes Technology for Children with Type 1 DiabetesMay 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
